Niagen Bioscience (NAGE) Cash from Investing Activities (2016 - 2025)
Niagen Bioscience (NAGE) has disclosed Cash from Investing Activities for 13 consecutive years, with -$101000.0 as the latest value for Q4 2025.
- Quarterly Cash from Investing Activities fell 46.38% to -$101000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$292000.0 through Dec 2025, down 104.2% year-over-year, with the annual reading at -$292000.0 for FY2025, 104.2% down from the prior year.
- Cash from Investing Activities for Q4 2025 was -$101000.0 at Niagen Bioscience, down from -$24000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$2000.0 in Q4 2021, with the low at -$265000.0 in Q2 2021.
- Average Cash from Investing Activities over 5 years is -$66050.0, with a median of -$43500.0 recorded in 2021.
- The sharpest move saw Cash from Investing Activities crashed 8500.0% in 2022, then skyrocketed 94.12% in 2023.
- Over 5 years, Cash from Investing Activities stood at -$2000.0 in 2021, then plummeted by 8500.0% to -$172000.0 in 2022, then surged by 87.79% to -$21000.0 in 2023, then tumbled by 228.57% to -$69000.0 in 2024, then tumbled by 46.38% to -$101000.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$101000.0, -$24000.0, and -$135000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.